Effect of Short-term Portable Air Purifier Use on Occupant Health Indicators
1 other identifier
interventional
72
1 country
1
Brief Summary
The purpose of this research project is to examine whether short-term use of portable air pollution filtration can result in changes in indoor airborne pollutants and impact on cardiovascular and respiratory health outcomes of the inhabitants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedFirst Submitted
Initial submission to the registry
December 10, 2015
CompletedFirst Posted
Study publicly available on registry
April 13, 2016
CompletedApril 13, 2016
March 1, 2016
1 month
December 10, 2015
April 7, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change from baseline FEV1 (forced expiratory volume in the first second of exhalation) within 2h after the filtration intervention
FEV1 (forced expiratory volume in the first second of exhalation, unit: liter) was measured by spirometry in all subjects within 2h after the filtration intervention to compare to FEV1 value of study subjects at baseline (i.e. at start of the study).
Within 2h after the filtration intervention
Change from baseline R5 (airway resistance measured at 5Hz) within 2h after the filtration intervention
R5 (airway resistance measured at 5Hz) was accessed by impulse oscillometry in all subjects within 2h after the filtration intervention to compare to the R5 value of study subjects at baseline (i.e. before the start of intervention).
Within 2h after the filtration intervention
Change in baseline exhaled nitric oxide (eNO) within 2h after the filtration intervention
Exhaled nitric oxide (eNO) was measured in all subjects within 2h after the filtration intervention to compare to the exhaled nitric oxide measurement of study subjects at baseline (i.e. before the start of intervention). Exhaled breath is collected in air sampling bags, and the concentration of NO was quantified by Thermo Scientific model 42i (NO-NO2-NOx) analyzer.
Within 2h after the filtration intervention
Change in exhaled nitric oxide (eNO) at 6h after filtration intervention compared to baseline
Exhaled nitric oxide (eNO) was measured in all subjects 6h after filtration intervention to compare to the exhaled nitric oxide measurement of study subjects at baseline (i.e. before the start of intervention). Exhaled breath is collected in air sampling bags, and the concentration of NO was quantified by Thermo Scientific model 42i (NO-NO2-NOx) analyzer.
6h after filtration intervention
Change from baseline PWV (pulse wave velocity) within 2h after the filtration intervention
PWV (pulse wave velocity) was measured by the VICORDER instrument in all subjects right after filtration intervention to compare to the PWV value measured at baseline (i.e. before the start of intervention).
Within 2h after the filtration intervention
Secondary Outcomes (6)
Change from baseline urinary biomarkers of inflammation and oxidative stress at 0h after the filtration intervention
At 0h after the filtration intervention
Change in baseline urinary biomarkers of inflammation and oxidative stress at 6h after filtration intervention
6h after filtration intervention
Change in baseline urinary biomarkers of inflammation and oxidative stress at 24h after filtration intervention
24h after filtration intervention
Changes in baseline blood biomarkers of inflammation, oxidative stress and coagulation within 1h after filtration intervention
Within 1h after filtration intervention
Changes in baseline blood biomarkers of inflammation, oxidative stress and coagulation right after filtration intervention
24h after filtration intervention
- +1 more secondary outcomes
Study Arms (2)
Group A: True-Washout-Sham
ACTIVE COMPARATORSubjects in group A receives true air filtration intervention, then at least two weeks of washout period, followed by sham air filtration intervention.
Group B: Sham-Washout-True
ACTIVE COMPARATORSubjects in group B receives sham air filtration intervention, then at least two weeks of washout period, followed by true air filtration intervention.
Interventions
This intervention involved three sequential steps: (1) 12 to 20 hours of true air filtration intervention; (2) at least two weeks of washout period; (3) 12 to 20 hours of sham air filtration intervention. In the indoor environment, the portable filtration device drew room air, sent it through filter and active carbon (for true filtration) or active carbon alone (sham filtration) and then delivered processed air back to room air. In the study the portable filtration device processes 2.8 cubic meter of room air per minute. The washout period lasted for at least two weeks where no filtration intervention was implemented.
This intervention involved three sequential steps: (1) 12 to 20 hours of sham air filtration intervention; (2) at least two weeks of washout period; (3) 12 to 20 hours of true air filtration intervention. In the indoor environment, the portable filtration device drew room air, sent it through filter and active carbon (for true filtration) or active carbon alone (sham filtration) and then delivered processed air back to room air. In the study the portable filtration device processes 2.8 cubic meter of room air per minute. The washout period lasted for at least two weeks where no filtration intervention was implemented.
Eligibility Criteria
You may qualify if:
- Healthy, non-smoking adults
- Live in the dormitory building at Shanghai First People's Hospital (South Section).
You may not qualify if:
- Current smokers
- Has any of the following diseases: chronic respiratory, cardiovascular, liver, renal, hematological disease; diabetes mellitus;
- Has any other diseases that may confound or complicate the effects of the intervention
- Pregnant females
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicinelead
- Duke Universitycollaborator
- Tsinghua Universitycollaborator
- Rutgers Universitycollaborator
Study Sites (1)
Shanghai First People's Hospital
Shanghai, Shanghai Municipality, 201620, China
Study Officials
- PRINCIPAL INVESTIGATOR
Junfeng Zhang, PhD
Duke University
- PRINCIPAL INVESTIGATOR
Yinping Zhang, PhD
Tsinghua University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
December 10, 2015
First Posted
April 13, 2016
Study Start
November 1, 2015
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
April 13, 2016
Record last verified: 2016-03